(IBDQ) iShares iBonds Dec 2025 - Ratings and Ratios
Corporate Bonds, Investment Grade, 2025 Maturity
Dividends
| Dividend Yield | 4.10% |
| Yield on Cost 5y | 4.39% |
| Yield CAGR 5y | 8.52% |
| Payout Consistency | 93.3% |
| Payout Ratio | - |
| Risk via 5d forecast | |
|---|---|
| Volatility | 0.70% |
| Value at Risk 5%th | 1.12% |
| Relative Tail Risk | -2.84% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.13 |
| Alpha | 0.15 |
| CAGR/Max DD | 2.66 |
| Character TTM | |
|---|---|
| Hurst Exponent | |
| Beta | 0.006 |
| Beta Downside | 0.004 |
| Drawdowns 3y | |
|---|---|
| Max DD | 1.82% |
| Mean DD | 0.14% |
| Median DD | 0.00% |
Description: IBDQ iShares iBonds Dec 2025 November 09, 2025
The iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) is a target-maturity fund that must allocate at least 80 % of its net assets to the securities that comprise its underlying index, and at least 90 % to U.S.-dollar-denominated, taxable, investment-grade corporate bonds that mature between 1 Jan 2025 and 15 Dec 2025.
Key market data (as of Nov 2025) suggest the ETF’s weighted-average yield sits near 4.7 % with an expense ratio of 0.15 %. The portfolio’s average credit quality is A- (S&P) and its sector exposure is tilted toward industrials (≈30 %) and consumer discretionary (≈20 %). Because the fund’s duration is locked to a 2025 endpoint, its price is highly sensitive to short-term interest-rate moves; a 25 bps shift in the Fed funds target could translate into roughly a 0.5 % change in NAV, assuming a modified duration of about 2 years.
For a deeper, data-driven look at IBDQ’s risk-adjusted return profile and its exposure to evolving credit spreads, the ValueRay platform provides a granular, interactive dashboard that can help you validate the assumptions above.
What is the price of IBDQ shares?
Over the past week, the price has changed by +0.00%, over one month by +0.26%, over three months by +0.95% and over the past year by +4.35%.
Is IBDQ a buy, sell or hold?
What are the forecasts/targets for the IBDQ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 26.9 | 7.2% |
IBDQ Fundamental Data Overview December 18, 2025
Beta = 0.17
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 2.32b USD (2.32b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 2.32b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 2.32b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.04% (E(2.32b)/V(2.32b) * Re(6.04%) + (debt-free company))
Discount Rate = 6.04% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for IBDQ ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle